Preventing opportunistic infections.
Cheng
B
B
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000212:Acyclovir / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003022:Clotrimazole / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D003622:Dapsone / Q000627:therapeutic use; D015725:Fluconazole / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D015270:Mycobacterium avium-intracellulare Infection / Q000517:prevention & control*; D009181:Mycoses / Q000517:prevention & control*; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use; D017828:Rifabutin / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000517:prevention & control*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
D017828:Rifabutin; D017964:Itraconazole; D002981:Clindamycin; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015725:Fluconazole; D003622:Dapsone; D003022:Clotrimazole; D017291:Clarithromycin; D014633:Valine; D000077483:Valacyclovir; D015774:Ganciclovir; D002955:Leucovorin; D000212:Acyclovir; D011739:Pyrimethamine